- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02196779
Laser Fluorescent Imaging of Abdominal Skin During Abdominoplasty
Study Overview
Status
Conditions
Detailed Description
Protocol
Laser Fluorescent Imaging of Abdominal Skin During Abdominoplasty.
Background/Purpose
Abdominoplasty (tummy tuck) is a common cosmetic operation. One of the risks of surgery is delayed wound healing caused by impaired circulation to the skin. In an effort to reduce risk, some investigators1 advocate a limited-undermining technique, with preservation of the perforating blood vessels and preservation of the Scarpa fascia of the lower abdomen. However, there is no evidence that this limited-undermining technique improves blood supply compared with a traditional abdominoplasty dissection. Such a limited dissection may compromise the cosmetic result.
This study was undertaken to investigate the blood supply of the abdominal skin during the abdominoplasty procedure. By testing the circulation at two points during the dissection, and a third time after completion of the operation, data may be obtained and used to evaluate the effect of the extent of the dissection on blood supply of the skin flap.
Laser fluorescent imaging represents an objective measurement technique that has been used to quantitate blood supply in skin flaps and other tissues. It has been used for several years to monitor the vascularity of flaps used in breast reconstruction. This technique has also been used previously in patients undergoing abdominoplasty.2
Subjects
Twenty consecutive consenting adult men and women undergoing outpatient elective abdominoplasty will be investigated using laser fluorescent imaging. By testing the blood supply at three time points, the patient serves as his or her own control.
Imaging
The SPY Elite Intraoperative Perfusion Assessment System (Lifecell Corp., Branchburg, NJ) consists of a near-infrared laser that detects fluorescence. The imaging agent, indocyanine green, is absorbed at this region of the spectrum, 800-810 nm. The imaging agent is injected intravenously. Starting within 5-10 seconds of injection, the system records images of the abdomen, showing the fluorescence, which indicates blood supply. The half-life of the imaging agent is 2.5-3 minutes. The imaging agent is metabolized by the liver. The only known risk is an allergic reaction to the imaging agent. Patients with a history of an allergic reaction to iodinated contrast dyes are excluded.
Surgery
The lipoabdominoplasty technique is performed as described by Saldanha et al.1 Following this limited dissection, 3 mL (7.5 mg) of indocyanine green is injected and the abdominal image is recorded, documenting blood supply to the lower abdomen. After further dissection, another 3 mL of imaging agent is injected and the lower abdomen is re-imaged. On completion of surgery, a third injection is administered and a final image is recorded.
Null Hypothesis
A traditional abdominoplasty dissection does not compromise circulation compared with a more limited dissection technique.
Informed Consent
Patients are informed as to the nature of the study and are told that their participation is entirely voluntary and they are free to decline, and that doing so does not in any way prejudice their treatment. Patients are informed of the small risk of an allergic reaction that will be treated if it occurs.
Patient Risk
There is no patient risk apart from a very small risk of allergic reaction, which is further reduced by excluding any patient with a known allergy to iodinated contrast dye. The study does not affect patient treatment. It offers the possibility of detection of reduced skin circulation, information that can be used by the surgeon to limit the dissection if necessary and avoid tissue loss and delayed wound healing, known complications of abdominoplasty.
Sample Size
A sample of 20 patients is anticipated, treated over a period of approximately 6 months.
Disclosure
The author has no financial interest in any of the products, devices, or drugs mentioned in this article. The author has no conflicts of interest to disclose. There was no outside funding for this study.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Kansas
-
Leawood, Kansas, United States, 66211
- Swanson Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients undergoing abdominoplasty
Exclusion Criteria:
- Allergy to iodinated contrast agents
- Nonconsenting patients
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients undergoing abdominoplasty
Skin circulation to abdominal flap is evaluated during surgery using laser fluorescent imaging.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Skin circulation during abdominoplasty.
Time Frame: 6 months
|
The blood supply to the skin is evaluated intraoperatively using laser fluorescent imaging.
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Eric Swanson, M.D., Swanson Center
Publications and helpful links
General Publications
- Roostaeian J, Harris R, Farkas JP, Barton FE, Kenkel JM. Comparison of Limited-Undermining Lipoabdominoplasty and Traditional Abdominoplasty Using Laser Fluorescence Imaging. Aesthet Surg J. 2014 Jul;34(5):741-7. doi: 10.1177/1090820X14532286. Epub 2014 Jul 1.
- Swanson E. Comparison of Limited and Full Dissection Abdominoplasty Using Laser Fluorescence Imaging to Evaluate Perfusion of the Abdominal Skin. Plast Reconstr Surg. 2015 Jul;136(1):31e-43e. doi: 10.1097/PRS.0000000000001376.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Swanson 003
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Skin Redundancy
-
Ethicon Endo-SurgeryCompletedSkin and Fat Redundancy and Muscle DiastasesUnited States, Argentina, Germany, Mexico
-
PfizerCompletedComplicated Skin and Skin Structure Infections | Complicated Intra-abdominal InfectionsPhilippines
-
PfizerCompletedIntra-Abdominal Infections | Skin Disease, Infectious | Soft Tissues Infections
-
Cairo UniversityCompletedAbdominal Wall Viability | Abdominal Wall Laxity | Abdominal LipodystrophyEgypt
-
Sheba Medical CenterUnknownBreast Cancer | Lung Cancer | Tumor Motion | "Continuous Positive Airway Pressure" | Abdominal TumorsIsrael
-
Tianjin Medical University Cancer Institute and...UnknownAbdominal Infection | Abdominal TumorChina
-
University of Health Sciences LahoreActive, not recruitingWaist Circumference | Abdominal Muscles Strength | Abdominal Muscles Endurance | Abdominal Muscles FlexibilityPakistan
-
Peking University Third HospitalRecruiting
-
Assiut UniversityUnknownPenetrating Abdominal Trauma
-
MedRegen LLCCompletedWound of Skin | Abdominal WoundUnited States